Page last updated: 2024-11-04

sk&f 86002 and Parkinson Disease

sk&f 86002 has been researched along with Parkinson Disease in 1 studies

6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole: inhibits p38 MAP kinase

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Iba, M1
Kim, C1
Kwon, S1
Szabo, M1
Horan-Portelance, L1
Peer, CJ1
Figg, WD1
Reed, X1
Ding, J1
Lee, SJ1
Rissman, RA1
Cookson, MR1
Overk, C1
Wrasidlo, W1
Masliah, E1

Other Studies

1 other study available for sk&f 86002 and Parkinson Disease

ArticleYear
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD.
    Science translational medicine, 2023, 05-10, Volume: 15, Issue:695

    Topics: alpha-Synuclein; Animals; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 14; Neuro

2023